Consequences of GATA-1 deficiency in megakaryocytes and platelets

Blood

Volumn 93, Issue 9, 1999, Pages 2867-2875

  Vyas, Paresh ^a   Ault, Kenneth ^b   Jackson, Carl W ^b   Orkin, Stuart H ^b   Shivdasani, Ramesh A ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR GATA 1;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CELL PROLIFERATION; COLONY FORMATION; ENDOPLASMIC RETICULUM; HEMATOPOIETIC CELL; MEGAKARYOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTOPOIESIS;

EID: 0033134831     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.9.2867.409k24_2867_2875     Document Type: Article

References (40)

1. Orkin SH: Transcription factors and hematopoietic development. J Biol Chem 270:4955, 1995
2. Shivdasani RA, Orkin SH: The transcriptional control of hematopoiesis. Blood 87:4025, 1996
3. Mouthon M-A, Bernard O, Mitjavila M-T, Romeo P-H, Vainchenker W, Mathieu-Mahul D: Expression of tal-1 and GATA-binding proteins during human hematopoiesis. Blood 81:647, 1993
4. Elwood MJ, Zogos H, Pereira DS, Dick JE, Begley CG: Enhanced megakaryocyte and erythroid development from normal human CD34+ cells: Consequences of enforced expression of SCL. Blood 91:3756, 1998
5. Lemarchandel V, Ghysdael J, Mignotte V, Rahuel C, Romeo P-H: GATA and Ets cis-acting sequences mediate megakaryocyte-specific expression. Mol Cell Biol 13:668, 1993
6. Uzan G, Prenant M, Prandini M-H, Martin F, Marguerie G: Tissue-specific expression of the platelet GPIIb gene. J Biol Chem 266:8932, 1991
7. Block KL, Ravid K, Phung QH, Poncz M: Characterization of regulatory elements in the 5′-flanking region of the rat GPIIb gene by studies in a primary rat marrow culture system. Blood 84:3385, 1994
8. Shivdasani RA, Fujiwara Y, McDevitt MA, Orkin SH: A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J 16:3965, 1997
9. Shivdasani RA, Rosenblatt MF, Zucker-Franklin D, Jackson CW, Hunt P, Saris C, Orkin SH: Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell 81:695, 1995
10. Tsang AP, Visvader JE, Turner CA, Fujiwara Y, Yu C, Weiss MJ, Crossley M, Orkin SH: FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation. Cell 90:109, 1997
11. Tsang AP, Fujiwara Y, Horn DB, Orkin SH: Failure of megakaryopoiesis and arrested erythropoiesis in mice lacking the GATA-1 transcriptional cofactor FOG. Genes Dev 12:1176, 1998
12. Visvader JE, Elefanty AG, Strasser A, Adams JM: GATA-1 but not SCL induces megakaryocytic differentiation in an early myeloid line. EMBO J 11.-4557, 1992
13. Visvader J, Adams JM: Megakaryocytic differentiation induced in 416B myeloid cells by GATA-2 and GATA-3 transgenes or 5-azacytidine is tightly coupled to GATA-1 expression. Blood 82:1493, 1993
14. Kulessa H, Frampton J, Graf T: GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts, and erythroblasts. Genes Dev 9:1250, 1995
15. Pevny L, Lin C-S, D'Agati V, Simon MC, Orkin SH, Costantini F: Development of hematopoietic cells lacking transcription factor GATA-1. Development 121:163, 1995
16. Takahashi S, Komeno T, Suwabe N, Yoh K, Nakajima O, Nishimura S, KurohaT, Yamamoto M: Role of GATA-1 in proliferation and differentiation of definitive erythroid and megakaryocytic cells in vivo. Blood 92:434, 1998
17. Villeval J-L, Cohen-Solal K, Tulliez M, Giraudier S, Guichard J, Burstein SA, Cramer EM, Vainchenker W, Wendling F: High thrombopoietin production by hemopoietic cells induces a fatal myeloproliferative syndrome in mice. Blood 90:4369, 1997
18. Jackson CW: Cholinesterase as a possible marker for early cells of the megakaryocytic series. Blood 42:413, 1973
19. Levine RF, Fedorko ME: Isolation of intact megakaryocytes from guinea pig femoral marrow. Successful harvest made possible with inhibitors of platelet aggregation; enrichment achieved with a two-step separation technique. J Cell Biol 69:159, 1976
20. McDonald T, Jackson CW: Thrombopoietin derived from human embryonic kidney cells stimulates an increase in DNA content of murine megakaryocytes in vivo. Exp Hematol 18:758, 1990
21. Krishan A: Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol 66:188, 1975
22. Jackson CW, Brown KL, Somerville BC, Lyles SA, Look AT: Two-color flow cytometric measurement of DNA distributions of rat megakaryocytes in unfixed unfractionated marrow cell suspensions. Blood 63:768, 1984
23. Weiss MJ, Keller G, Orkin SH: Novel insights into erythroid development revealed through in vitro differentiation of GATA-1-embryonic stem cells. Genes Dev 8:1184, 1994
24. Stenberg PE, Barrie RJ, Pestina TI, Steward SA, Arnold JT, Murti AK, Hutson NK, Jackson CW: Prolonged bleeding time with defective platelet filopodia formation in the Wistar Furth rat. Blood 91:1599, 1998
25. Shivdasani RA, Fielder P, Keller G-A, Orkin SH, de Sauvage FJ: Regulation of the serum concentration of thrombopoietin in thrombocytopenic NF-E2 knockout mice. Blood 90:1821, 1997
26. Dejana E, Villa S, de Gaetano G: Bleeding time in rats: A comparison of different experimental conditions. Thromb Haemost 48:108, 1982
27. Ault KA, Knowles C: In vivo biotinylation demonstrates that reticulated platelets are the youngest platelets in the circulation. Exp Hematol 23:996, 1995
28. Ault KA, Knowles C, Mitchell J, Brown CL, Schulz KL, Beamer WG: Genetic control of platelet activation in inbred mouse strains. Platelets 8:235, 1997
29. Bessman JD, Gilmer PR, Gardner FH: Use of mean platelet volume improves detection of platelet disorders. Blood Cells 11:127, 1985
30. Bunting S, Widmer R, Lipari T, Rangell L, Steinmetz H, Carver-Moore K, Moore MW, Keller G-A, de Sauvage FJ: Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin. Blood 90:3423, 1997
31. Weiss MJ, Orkin SH: Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis. Proc Natl Acad Sci USA 92:9623, 1995
32. Hashimoto Y, Ware J: Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Iba gene. J Biol Chem 270:24532, 1995
33. Yagi M, Edelhoff S, Disteche CM, Roth GJ: Structural characterization and chromosomal location of the gene encoding human platelet glycoprotein Ib beta. J Biol Chem 269:17424, 1994
34. Deveaux S, Filipe A, Lemarchandel V, Ghysdael J, Romeo P-H, Mignotte V: Analysis of the thrombopoietin receptor (MPL) promoter implicates GATA and Ets proteins in the coregulation of megakaryocyte-specific genes. Blood 87:4678, 1996
35. Ravid K, Doi T, Beeler DL, Kuter DJ, Rosenberg RD: Transcriptional regulation of the rat platelet factor 4 gene: Interaction between an enhancer/silencer domain and the GATA site. Mol Cell Biol 11:6116, 1991
36. Hickey MJ, Roth GJ: Characterization of the gene encoding human platelet glycoprotein IX. J Biol Chem 268:3438, 1993
37. Seshasayee D, Gaines P, Wojchowski DM: GATA-1 dominantly activates a program of erythroid gene expression in factor-dependent myeloid FDCW2 cells. Mol Cell Biol 18:3278, 1998
38. Orkin SH: GATA-binding transcription factors in hematopoietic cells. Blood 80:575, 1992
39. Ludlow LB, Schick BP, Budarf ML, Driscoll DA, Zackai EH, Cohen A, Konkle BA: Identification of a mutation in a GATA binding site of the platelet glycoprotein Ibb promoter resulting in the Bernard-Soulier syndrome. J Biol Chem 271:22076, 1996
40. Lecine P, Villeval J-L, Vyas P, Swencki B, Xu Y, Shivdasani RA: Mice lacking transcription factor NF-E2 provide in vivo validation of the proplatelet model of thrombocytopenia and show a platelet production defect that is intrinsic to megakaryocytes. Blood 92:1608, 1998